# atovaquone

NDC: 68462-421
Generic name: atovaquone
Labeler / Manufacturer: Glenmark Pharmaceuticals Inc., USA
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20171231

FDA application: ANDA209685

## Active ingredients

- ATOVAQUONE: 750 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68462-421"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68462-421
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9045ba6f-938e-4717-bfa2-a3efe52f04cd